Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 6/20 | 0.56 |
| ▸ | DGKA | P23743 | 1/20 | 0.52 |
| ▸ | LMNA | P02545 | 2/20 | 0.48 |
| ▸ | PAM | P19021 | 2/20 | 0.47 |
| ▸ | MAPT | P10636 | 2/20 | 0.46 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.46 |
| ▸ | CES2 | O00748 | 3/20 | 0.45 |
| ▸ | CES1 | P23141 | 3/20 | 0.45 |
| ▸ | PPARG | P37231 | 4/20 | 0.43 |
| ▸ | PPARD | Q03181 | 4/20 | 0.43 |
| ▸ | PPARA | Q07869 | 4/20 | 0.43 |
| ▸ | GPR84 | Q9NQS5 | 3/20 | 0.43 |
| ▸ | HDAC11 | Q96DB2 | 3/20 | 0.43 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.43 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.43 |
| ▸ | SLC22A6 | Q4U2R8 | 1/20 | 0.43 |
| ▸ | SLC22A8 | Q8TCC7 | 1/20 | 0.43 |
| ▸ | TLR2 | O60603 | 1/20 | 0.43 |
| ▸ | MEN1 | O00255 | 1/20 | 0.43 |
| ▸ | ESR1 | P03372 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28098258 | 1.00 | TSHR (0.56) | TSHRDGKALMNAPAMMAPT | |
| SCHEMBL31489098 | 1.00 | TSHR (0.56) | TSHRDGKALMNAPAMMAPT | |
| SCHEMBL28181994 | 1.00 | TSHR (0.56) | TSHRDGKALMNAPAMMAPT | |
| SCHEMBL31616876 | 1.00 | TSHR (0.56) | TSHRDGKALMNAPAMMAPT | |
| SCHEMBL2723395 | 1.00 | TSHR (0.56) | TSHRDGKALMNAPAMMAPT | |
| SCHEMBL4183714 | 1.00 | TSHR (0.56) | TSHRDGKALMNAPAMMAPT | |
| SCHEMBL9305959 | 1.00 | TSHR (0.56) | TSHRDGKALMNAPAMMAPT | |
| SCHEMBL3384487 | 1.00 | TSHR (0.56) | TSHRDGKALMNAPAMMAPT | |
| SCHEMBL3951614 | 1.00 | TSHR (0.56) | TSHRDGKALMNAPAMMAPT | |
| SCHEMBL27857013 | 1.00 | TSHR (0.56) | TSHRDGKALMNAPAMMAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 40 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4041694-A1 | STORAGE-STABLE MULTI-COMPONENT REACTION RESIN SYSTEM AND USE THEREOF | Hilti Aktiengesellschaft (LI) | 2022-08-17 | — | — | EP | claimed |
| CN-115340739-B | Preparation method of electrically polarized particles with molecular imprinting and application of electrically polarized particles in electrically polarized color-changing optical film | 绍兴迪飞新材料有限公司 | 2024-07-16 | — | — | CN | disclosed |
| CN-118043290-A | Brick powder as filler in multicomponent systems for chemical fastening | 喜利得股份公司 | 2024-05-14 | — | — | CN | disclosed |
| EP-3649169-B1 | URETHANE METHACRYLATE COMPOUNDS CONTAINING REACTIVE RESINS, AND REACTIVE RESIN SYSTEMS AND THEIR USE | HILTI AG (LI) | 2024-03-20 | — | — | EP | disclosed |
| EP-4041694-A1 | STORAGE-STABLE MULTI-COMPONENT REACTION RESIN SYSTEM AND USE THEREOF | Hilti Aktiengesellschaft (LI) | 2022-08-17 | — | — | EP | disclosed |
| CN-114449998-A | Oral delivery dosage form hydrogels, methods of making and methods of using the same | 保罗·道格拉斯·戈德弗林 | 2022-05-06 | — | — | CN | disclosed |
| EP-3938409-A1 | ACCELERATOR COMBINATION | Hilti Aktiengesellschaft (LI) | 2022-01-19 | — | — | EP | disclosed |
| EP-3850030-A1 | REACTIVE AMINE ACCELERATOR, REACTIVE RESIN CONTAINING THE SAME, AND USE THEREOF | Hilti Aktiengesellschaft (LI) | 2021-07-21 | — | — | EP | disclosed |
| EP-3717435-A1 | ISOSORBIDE DERIVATIVES AS REACTIVE ADDITIVES IN REACTIVE RESINS AND CHEMICAL DOWELS | Hilti Aktiengesellschaft (LI) | 2020-10-07 | — | — | EP | disclosed |
| WO-2020187565-A1 | ACCELERATOR COMBINATION | HILTI AKTIENGESELLSCHAFT (LI) | 2020-09-24 | — | — | WO | disclosed |
| EP-1592786-B8 | DIAGNOSIS AND TREATMENT OF MULTIPLE SULFATASE DEFICIENCY AND OTHER SULFATASE DEFICIENCIES USING A FORMYLGLYCINE GENERATING ENZYME (FGE) | SHIRE HUMAN GENETIC THERAPIES (US) | 2012-03-21 | — | — | EP | disclosed |
| EP-2217701-A2 | GLUCAGON ANTAGONISTS | Indiana University Research and Technology Corporation (US) | 2010-08-18 | — | — | EP | disclosed |
| CN-101468893-A | Dual component thermosetting resin and its use | HILTI AG (LI) | 2009-07-01 | — | — | CN | disclosed |
| WO-2009058662-A2 | GLUCAGON ANTAGONISTS | INDIANA UNIVERSITY RESEARCH AND TECHNOLOGY CORPORATION (US) | 2009-05-07 | — | — | WO | disclosed |
| WO-2009047799-A1 | HIGH DOSE SOLID UNIT ORAL PHARMACEUTICAL DOSAGE FORM OF MYCOPHENOLATE SODIUM AND PROCESS FOR MAKING SAME | PANACEA BIOTEC LIMITED (IN) | 2009-04-16 | — | — | WO | disclosed |
| WO-2006062608-A2 | TUNABLE VEHICLE STRUCTURAL MEMBERS AND METHODS FOR SELECTIVELY CHANGING THE MECHANICAL PROPERTIES THERETO | GENERAL MOTORS CORPORATION (US) | 2006-06-15 | — | — | WO | disclosed |
| EP-1592786-A2 | DIAGNOSIS AND TREATMENT OF MULTIPLE SULFATASE DEFICIENCY AND OTHER USING A FORMYLGLYCINE GENERATING ENZYME (FGE) | Transkaryotic Therapies, Inc. (US) | 2005-11-09 | — | — | EP | disclosed |
| WO-2004072275-A2 | DIAGNOSIS AND TREATMENT OF MULTIPLE SULFATASE DEFICIENCY AND OTHER USING A FORMYLGLYCINE GENERATING ENZYME (FGE) | TRANSKARYOTIC THERAPIES, INC. (US) | 2004-08-26 | — | — | WO | disclosed |
| EP-1328261-A2 | TREATMENT OF NEURODEGENERATIVE DISEASE | Minerva Biotechnologies Corporation (US) | 2003-07-23 | — | — | EP | disclosed |
| WO-2001078709-A2 | TREATMENT OF NEURODEGENERATIVE DISEASE | MINERVA BIOTECHNOLOGIES CORPORATION (US) | 2001-10-25 | — | — | WO | disclosed |